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Abstract.  Yeast mutants that are defective in 
acidification of the lysosome-like vacuole are able to 
grow at pH 5.5, but not at pH 7.  Here, we present evi- 
dence that endocytosis is required for this low pH- 
dependent growth and use this observation to develop 
a screen for mutants defective in endocytosis. By iso- 
lating mutants that cannot grow when they lack the 
60-kD vacuolar ATPase subunit (encoded by the VAT2 
gene), we isolated a number of vat2-synthetic  lethal 
(Vsl-) mutant strains. Seven of the Vsl- mutants are 
defective in endocytosis. Four of these mutant strains 
(endS-l,  end9-1,  endlO-l,  and end11-1 ) show altered up- 
take of the endocytosed ligand, a-factor, and three 
(end124,  endl2-2,  and end134 ) are probably defective 
in transfer of internalized material to the vacuole. 
Most of the mutations also confer a strong Ts- growth 
defect. The mutants defective in uptake of or-factor 
sort newly synthesized vacuolar proteins correctly, 
while those which may be defective in subsequent 
transport steps secrete at least a fraction of the newly 
synthesized soluble vacuolar proteins. The mutations 
that result in a defect in u-factor uptake are not allelic 
to any of the genes previously shown to encode endo- 
cytic functions. 
NDOCYTOSIS is a general mechanism that allows eu- 
karyotic ceils to internalize both plasma membrane 
and extracellular  material.  Experiments  with  cul- 
tured mammalian cells (where endocytosis has been well- 
characterized  at a morphological  level) have demonstrated 
that fluid-phase markers such as horseradish peroxidase or 
colloidal gold particles are internalized and can be visualized 
in cell sections by electron microscopy (Hopkins and Trow- 
bridge,  1983; Steiuman et al., 1983). After short periods of 
internalization,  the markers are seen in invaginations of the 
plasma membrane  known as coated pits (Anderson et al., 
1977; Hopkins  and Trowbridge,  1983). These pits bear a 
coat composed of polymerized clathrin on their cytoplasmic 
face which has been implicated in the rapid internalization 
of most, but not all, endocytic markers (Pearse and Robin- 
son,  1990; Hansen et al.,  1993). After longer incubation 
times, the markers label peripheral  early endosomes which 
have a  tubuloreticular  profile  in cell  sections  and subse- 
quently  perinuclear,  late  endosomes  which have a  multi- 
vesicular structure and which contain mannose 6-phosphate 
receptors  (Helenius et al., 1983; Hopkins and Trowbridge, 
1983; Gritiiths et al.,  1988). 
The mechanism of transport of markers from early to late 
endosomes is unclear. Transport may occur via budding and 
fusion of transport  vesicles  or  by  a  maturation process 
(Griffiths  and  Gruenberg,  1991; Murphy,  1991). In  any 
event, after prolonged internalization,  the bulk of the non- 
specific markers are localized in lysosomes, which are the 
major degradative compartments in the cell and are the site 
where all fluid-phase markers eventually accumulate (Korn- 
feld and Mellman,  1989). The rate of endocytosis of fluid as 
estimated  using  lucifer  yellow-carbohydrazide  (LY)  I may 
vary between cell types,  but in murine peritoneal  macro- 
phages  an estimate  is 250  nl/mg of cellular  protein/hour 
(Swanson et al.,  1985). 
Endocytosis of  extracellular fluid by S. cerevisiae has been 
demonstrated using LY. Uptake of LY leads to its accumula- 
tion in the vacuole (the yeast equivalent of the mammalian 
lysosome) and is time-, energy-, and temperature-dependent, 
consistent with an endocytic mechanism (Riezman,  1985). 
The rate of endocytosis has been estimated as 27 nl/mg of 
cellular  protein/hour  at 30°C (Riezman,  1985). The mat- 
ing pheromone a-factor is a marker for receptor-mediated 
endocytosis  in yeast and  is  internalized  while  bound  to 
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(Chvatchko et al.,  1986; Jenness and Spatrick, 1986; Duli6 
et al.,  1991).  Internalized a-factor is transported through 
two  intermediate  compartments  en  route  to  the  vacuole 
where it is degraded by resident vacuolar proteases (Singer 
and Riezman,  1990; Singer-Kriiger et al.,  1993). 
Recently, two mutants, end3-1 and end4-1, that are defec- 
tive for both fluid-phase and receptor-mediated endocytosis, 
but have no defect in vacuolar protein biogenesis have been 
isolated and characterized (Raths et al., 1993). Mutations in 
END3 or END4 lead to defects in the internalization step of 
endocytosis. This step also requires actin and the actin fila- 
ment-bundling protein, fimbrin (AC'//and SAC6 gene prod- 
ucts) (Kiibler and Riezman,  1993).  Tan et al.  (1993) have 
shown that clathrin heavy chain (CHC1  gene product) also 
plays an important role in the internalization step of endocy- 
tosis in yeast. 
Fewer mutants exist that specifically affect later stages of 
endocytosis in yeast. Mutations in the YPT51/VPS21 (Singer- 
Kriiger et al.,  1994;  Horazdovsky et al.,  1994) and YPT7 
(Wichmann et al.,  1992; Schimm611er and Riezman, 1993) 
genes, which encode putative small GTPases of the rab fam- 
ily, specifically affect delivery of internalized material to the 
vacuole, but also affect vacuole biogenesis. Another mutant, 
renl/vps2, may also affect a late step in the endocytic pathway 
(Davis et al.,  1993). 
The vacuolar system of the yeast cell, and possibly other 
organdies,  are  acidified  by  the  action  of a  membrane- 
associated H÷-ATPase which in yeast comprises at least 10 
subunits of sizes 102, 95, 69, 60, 54, 42, 36, 32, 27, and 17 
kD (Ho et al.,  1993; Manolson et al.,  1994).  The 60-kD 
subunit is encoded by the VA/2 gene (Nelson et al.,  1989; 
Yamashiro et al., 1990). In strains bearing a disruption mu- 
tation of VAl2(vat2A), the ATPase does not assemble on the 
vacuolar membrane and consequently the lumen of the vacu- 
ole fails to become acidified (Yamashiro et ai., 1990). vat2A 
strains can grow if the external medium is between pH 5 and 
pH 6, but are unable to grow if the medium is buffered at 
pH 7 or above (Nelson and Nelson, 1990; Yamashiro et al., 
1990). Nelson and Nelson (1990) have proposed that in the 
absence of  vacuolar ATPase activity, fluid-phase endocytosis 
may be sufficient to acidify endocytic compartments when 
the external medium is acidic. This is illustrated in Fig.  1 
(see Results). When the external medium is of low pH, the 
vacuolar system may be acidified either by ATPase-driven 
H ÷ pumping or by endocytosis. 
Here we provide experimental evidence that endocytosis 
is indeed required for growth of vat2A  mutant strains on 
acidic medium and we have exploited this observation to iso- 
late new end mutants that are defective in specific steps of 
transport from the external environment to the vacuole. 
Materials and Methods 
Media,  Yeast Strains,  and Reagents 
All the yeast strains described  in this report  are listed in Table I with their 
respective genotypes. YPUAD was as described  previously (Duli~ et al., 
Table L  Yeast Strains  Used in  This Study 
Strain  Genotype  Source 
RH144-3A  MATt~ his4 leu2 ura3 barl  Lab. strain 
RH144-3D  MATa his4 leu2 ura3 bar1 
RH449  MATct his4 leu2 ura3 lys2 barl 
RH977  MATc~ his4 leu2 ura3 trp  l : : URA3 barl  " 
RH978  MATa his4 leu2 ura3 trpl::URA3 barl  " 
RHI606  MATa vat2A ::LEU2 leu2 ura3 ade6 his4 barl  " 
RH1931  RH1994 x  RH1606 diploid  _  This study 
RH1937  MATa vat2A: :LEU2 leu2 ura3 ade6 his4 barl /pCY36 
# 
RH1966  MATc~ his4 leu2 ura3 lys2 barl end4A::LEU 2  " 
RH1972  MATa vat2  A : :LEU2 leu2 ura3 ade6 his4 end13-1 bar1/pCY36  This study 
RH1973  MATa vat2A  ::LEU2 leu2 ura3 ade6 his4 endS-1 barl/pCY36  " 
RH1974  MATa vat2A::LEU2 leu2 ura3 ade6 his4 endl2-1 barl/pCY36  " 
RH1975  MATa vat2A::LEU2 leu2 ura3 ade6 his4 endl2-2 barlbpCY36  " 
RH1976  MATa vat2A ::LEU2 leu2 ura3 ade6 his4 endg-I barl/pCY36  " 
RH1977  MATa vat2A ::LEU2 leu2 ura3 ade6 his4 endlO-1 barl/pCY36  " 
RH1978  MATa vat2A : :LEU2 leu2 ura3 ade6 his4 endl l-1 barl/pCY36  " 
RH1994  MATct his4 leu2 ura3 barl  end3A::URA3  Lab.  stnfm 
RH2464  RH1966 x  RH1606 diploid  This study 
RH2604  MATa endl3-1  leu2 ura3 his4 barl 
RH2605  MATct endl3-1 leu2 ura3 his4 barl 
RH2607  MATa endS-1  leu2 ura3 his4 bar1 
RH2608  MATer endS-1  leu2 ura3 his4 barl 
RH2611  MATa endl2-1  leu2 ura3 his4 barl 
RH2612  MATct endl2-1  leu2 ura3 his4 barl 
RH2615  MATa end9-1  leu2 ura3 his4 barl 
RH2616  MAT~ end9-1  leu2 ura3 his4 barl 
RH2618  MATa endlO-1  leu2 ura3 his4 barl 
RH2619  MATc~ endlO-1  leu2 ura3 his4 barl 
RH2622  MATa endll-1  leu2 ura3 his4 barl 
RH2623  MATer endl l-1 leu2 ura3 his4 barl 
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growth of vat2A mutant strains the pH of the YPUAD was adjusted with 
HCI to 5 where specified. Minimal medium for plasmid selection was SD 
(Dull6 et al., 1991). Where specified, additional nutrients were added to the 
SD medium to give a 40-/~g/ml final concentration. SD contained one or 
several of  the following seven nutrient supplements when required: adenine, 
uracil, tryptophan, histidine, lysine, leucine, and tyrosine. The pH of our 
SD medium was 5.3-5.5. 
SD medium containing 5 fluoroorotic acid (5FOA) (1 mg/mi final con- 
centration) (SD/5FOA) was used to select for ceils which had been cured 
of URA3 plasmids (Boeke et al., 1984).  5FOA (PeR Inc., Gainsville, FL) 
was added to SD medium to  1 rng/rnl  final concentration and uracil was 
added to 50 t*g/ml final concentration. Additional supplements were added 
where required for growth and the pH was adjusted to 5.3-5.5 by addition 
of 10 M NaOH. The pH of SD/5FOA plates was the same as the SD plates. 
Where growth on SD/5FOA and SD was directly compared, e.g., during 
the mutant screen, the SD plates contained 50/zg/ml uracil in addition to 
the nutrients needed for growth. All solid media contained 2% Bactoagar 
(Difco, Detroit, M1).  SD (low sulfate) and SD (no sulfate) have been de- 
scribed (Raths et al.,  1993). 
~-Factor internalizations were performed using metabolically labeled 
[35S]a-factor purified essentially as described by Duli~ et al.,  1991. The 
procedure for biosynthetic labeling of a-factor was modified slightly; a 30- 
rain preincubation in SD (no sulfate) was included before the addition of 
the Na235SO4 label and labeling was for only 8 h, since this increased the 
yield of radiolabeled a-factor considerably. The Na235SO4 (40 mCi/ml) 
used for metabolic labeling was obtained from Amersham PLC (Amer- 
sham, UK). 
LY accumulation was assayed using LY obtained from Fluke (Buchs, 
Switzerland). ~-Factor degradation was assessed by separating intact from 
degraded a-factor on preparative silica gel 60 plates (2.2-mm-thick, 20  x 
20 era) thin layer chromatography plates supplied by Merck ([Switzerland] 
AG, Dietikon, Switzerland). Polyacrylamide gel electrophoresis was car- 
ried out as described by Laemmli (1970) using 7.5% polyacrylamide/SDS 
gels. Acrylarnide was obtained from BDH (Foole, UK) and sodium dodecyl 
sulfate was obtained from Sigma Chem. Co., St. Louis, MO. FOr fluorogra- 
phy, the gels were soaked first in water, and then in 1 M sodium salicylate 
pH  10 for 1 h, and then dried under vacuum. The gels were exposed to 
preflashed Kodak XAR X-ray film (Kodak, Rochester, NY) at -800C and 
developed using a Fuji automatic film developer. 
Yeast Genetic Techniques 
Mating of yeast cells, sporulation of diploid strains, tetrad dissection, and 
scoring of genetic markers was performed as described by Sherman et al. 
(1974).  Transformation of yeast cells was accomplished by the lithium ace- 
rate method of Ito et al. (1983).  Testing for temperature-sensitive growth 
was done by streaking yeast cells for single colonies on two YPUAD plates 
and incubating one plate for 3 d at 24°C and one plate for 3 d at 37°C. 
Mutagenesis and Colethality Screen 
The strain RH1937, which has the chromosomal copy of the VAT2 gene dis- 
rupted with LEU2 and carries a YCp50-based plasmid (pCY36;  Yamashiro 
et al.,  1990)  containing both the URA3 and the VA/2 genes, was used for 
isolation of vat2-synthetic lethal (Vsl-) mutants (Table D. The rationale for 
the screen is shown in Fig. 3. RH1937  cells were mutagenized and mutants 
that were unable to lose the pCY36 plasmid (thereby uncovering the vat2 
chromosomal  mutation)  were  identified by  their  inability  to  grow  on 
SD/5FOA. SD/5FOA selects for cells which do not have a wild-type URA3 
gene; in this case cells that have lost the pC'Y36 plasmid. 
The method used for mutagenizing yeast cells with ethyl methanesulfonic 
acid (EMS) (Sigma Chem. Co.) was described in Munn et al. (1991).  A 
treatment with EMS which resulted in 30% cell viability was used for the 
mutant screen. Approximately 7,000 colonies derived from RH1937  cells 
mutagenized in this way and selected for plasmid retention on SD plates 
lacking uracil (,~200 colonies per plate) were subjected to screening by 
replica plating onto SD and SD/5FOA selection plates containing uracil. 
Colonies which grew on SD, but not on SD/5FOA after replica plating were 
restreaked on both media and incubated at 24°C and 300C. Those isolates 
which grew on SD, but gave few or no colonies on SD/5FOA at both temper- 
atures were retained. In this way we isolated 18 mutants. 
LY  Accumulation Assays 
These were performed as described by Dull6 et al. (1991). All incubations 
were at 24°C for 1 h and the cells were vigorously aerated before incuba- 
tion. The cells were washed in 1 ml of ice-cold 50 mM sodium phosphate/ 
10 mM sodium azide/10 mM sodium fluoride pH 7.5 (SPAF) four times after 
incubation with LY. The cells were then resuspended in 30 #1 of SPAF and 
viewed by fluorescence microscopy as described by Duli~  et al. (1991). 
or-Factor Uptake Assays 
[35S]c~-factor uptake assays were performed on mid-log phase cells (107 
cells/mi) using the continuous presence protocol as described by Duli~ et 
al. (1991). The assays were carried out at 24°C and at 370C with a 15-min 
preshift before cx-factor addition. Internalization was calculated by dividing 
the internalized counts (pH 1-resistant)  by the total cell-associated counts 
(pH 6-resistant) for each time point, except in the case of the endlO-1 mu- 
tant. For the endlO-1 mutant, internalized a-factor was calculated by divid- 
ing pH l-resistant counts at each time point by the pH 6-resistant counts 
at 5 min. The cell-associated counts decreased very rapidly in this mutant 
at 37°C, probably due to dissociation of uninternalized a-factor from the 
receptor. 
or-Factor Degradation Assays 
[3SS]a-factor  degradation assays were performed on mid-log phase cells 
(107 celis/ml) using the pulse-chase ([3SS]c~-factor prebinding for 50 min 
on ice) protocol as described by Duli~ et al. (1991).  All assays were per- 
formed at 30°C, which is the optimal temperature for c~-factor degradation. 
Filter lmmunoblot for Detection of  Secreted CPY 
The secretion of CPY from yeast cells during growth was analyzed using 
the method described by Roberts et al. (1991).  Yeast cells were grown on 
YPUAD plates in contact with a 0.45-~m nitrocellulose filter (Schteicher 
and Schuell, Dassel, Germany) (overlaid after inoculation of the plate) at 
24°C. After incubation in contact with the filter for ,,o40--48 h, the filter 
was removed from the plate and the adherent yeast cells were eluted with 
water.  The filter was then blocked with PBS containing 0.1%  Tween 20 
(Merck) and 2% milk powder (PBSTM) for 2 h at room temperature. The 
filter was then incubated for 3 h with a polycional rabbit antiserum against 
CPY at 1:1,000 dilution in PBSTM. After washing three times in PBSTM, 
the filter was probed for 1 h with goat anti-rabbit IgG coupled to horserad- 
ish peroxidase (Sigma Immunochemicals) at  1:5,000 dilution in PBSTM. 
Immunoreactive protein bound to the filter was detected by enhanced che- 
miluminescence (ECL) using the Amersham system and exposure to Kodak 
XAR x-ray film. 
Metabolic Labeling of CPY 
Metabolic labeling of cells with Na235SO4, preparation of spheroplasts, ly- 
sis of the spheroplasts, and immuneprecipitation of the labeled CPY from 
the lysates were all carried out as previously described (Raths et al., 1993) 
with two modifications. First, the labelings were performed on cells which 
had been preshifted to 37°C for 15 min. Second, a protease inhibitor cock- 
tail was added to each fraction before addition of SDS and heating of the 
samples to 90°C. The final concentrations of protease inhibitors were: 0.5 
mM PMSF (Sigma Chem. Co.), 1/~g/mi pepstatin (Bonhringer-Mannheim 
Biochemicals,  Mannheim,  Germany),  1  /~g/mi  leupeptin  (Boehringer- 
Mannheim). Immuneprecipitates were electrophoresed on 7.5 % polyacryl- 
amide/SDS gels and analyzed by fluorography using Kodak XAR X-ray 
film.  The end8-1  mutant was labeled with [35S]methionine  and cysteine 
(ICN Biochemicals, Irvine, CA) using the method described by Munn et 
al.  (1991),  since it was found to label poorly with Na235SO4 at 37°C. 
Results 
Yeast Mutants Defective in Both 
Vacuolar Acidification and Endocytosis 
Are Inviable 
It has been postulated that (a) yeast mutants  which have a 
defective vacuolar H+-ATPase may be able to acidify their 
vacuoles  by  fluid phase  endocytosis  if they  are  grown in 
acidified medium and (b) that acidification of the vacuole ei- 
ther by H+-pumping  or by fluid-phase endocytosis of acidi- 
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son, 1990). The hypothesis that yeast cells can acidify their 
vacuoles by two independent pathways is illustrated schemat- 
ically in Fig. 1. To test whether yeast strains that are defective 
in both vacuolar acidification and  fluid-phase endocytosis 
are inviable, we attempted to construct strains carrying mu- 
tations in both VAT2 and END3, or in both VAT2 and END4. 
Yeast cells that carry a vat2A mutation are inviable at pH 7, 
but can grow even at 37°C on rich medinm between pH 5 
and  pH  6  (Nelson  and  Nelson,  1990;  Yamashiro  et  al., 
1990). In contrast, both end3A and end4A cells arc inviable 
at 37°C (Btnddctti, H., and L. Hick¢, personal communica- 
tion).  Two  diploid  strains,  heterozygous  for  vat2A  and 
end3A and for vat2A and end4A,  respectively, were sporu- 
lated, the resulting tetrads were dissected onto rich medium 
at pH 5, and the haploid spores were allowed to form colo- 
nies at 24°C  (see Materials and Methods).  The growth of 
haploid  colonies  from spores derived from the  end3A  × 
vat2A diploid is shown in Fig.  2.  Similar results were ob- 
tained  from dissection  of tetrads  from a  end4A  ×  vat2A 
diploid  (data  not  shown).  The  tetrads  derived  from both 
strains  were  of three  classes.  Approximately 25 %  of the 
tetrads contained four viable spores, 50 % of the tetrads con- 
tained three viable spores, and 25% of the tetrads contained 
only two viable spores (Table II, A and B),  suggesting that 
two mutations segregated independently in each cross and 
that the combination of the two mutations was lethal. The to- 
tal number of spores of each genotype obtained from the 
end3A × vat2A dissection are shown in Table II C. No viable 
Figure 1. Schematic representation of a yeast cell depicting the en- 
docytic  compartments  (pr/mary endocytic  vesicles,  early  endo- 
some, late endosome, and vacuole) and the Golgi apparatus. The 
compartments  that may have an acidified lumen are indicated by 
shading (in some cases the pH is only known for the mammalian 
counterpart).  According  to the  proposal  of Nelson  and  Nelson 
(1990) these compartments may be acidified in two ways. (/) Pro- 
tons may be pumped into the lumen of  the acidified organelles from 
the cytoplasm by the vacuolar H+-ATPase (the 60-kD  subunit of 
which is encoded by the VAT2 gene). (2) Protons may be taken up 
from the acidified external environment (pH 5.5) by fluid-phase en- 
docytosis, and acidification of  the various compartments may occur 
via transport  through the endocytic pathway. In wild-type (VAT2) 
yeast cells the vacuole has been shown to have a pH of  6 CYamashiro 
et al., 1990). The site of the endocytic block caused by the end3A 
and end4A mutations is indicated (Raths et al., 1993). A block in 
endocytosis in conjunction with a defective vacuolar ATPase would 
be predicted to prevent acidification of the vacuole even when the 
cells are grown on acidic medium. 
Figure 2. Tetrads derived from a diploid 
strain heterozygous for both end3A and 
vat2A. The diploid strain (RH1931) was 
sporulated  and  tetrads  were  dissected 
onto  YPUAD  medium  at  pH  5.  The 
spores  were allowed to germinate  and 
form colonies at 24°C. Note that many 
spores  did  not  give  rise  to  colonies. 
These spores were those that inherited 
both the end3A and vat2A mutations. 
vat2A  endA  double mutants  were recovered.  Presumptive 
vat2AendA  spores did  germinate in  most cases,  but  gave 
microcolonies of less than 200 cells in the case of end3A  x 
vat2A and less than 20 cells in the case of end4A  x  vat2A 
(data not shown). 
Isolation of  Mutants Synthetically Lethal with vat2A 
The  observation  that  both  end3  and  end4  mutations  are 
colethal with a vat2 mutation at pH 5 indicated that it might 
be possible to isolate additional end mutations by screening 
for vat2-synthetic lethal mutants (Vsl-), and then testing the 
Vsl- mutants for defects in endocytosis. We started with a 
strain which contains a chromosomal disruption of VAT2 and 
a centromere plasmid carrying both URA3 and the wild-type 
VAT2 gene (Table I). This strain is also MATa and bar1  so 
that it is possible to directly assay the mutants obtained from 
this strain for defects in <x-factor internalization. A  screen 
Was conducted (Fig.  3) and retesting of growth on SD and 
on SD/5FOA at both 24 and 30°C indicated that 18 isolates 
were most strongly affected for growth on SD/SFOA at both 
temperatures.  Mutants having defects at both 24 and 30°C 
were thought to be more likely to bear nonconditional muta- 
tions and therefore to affect nonessential genes. This ration- 
ale was predicted to favor isolation of mutants distinct from 
previously isolated mutants such as actl-1,  end2-1,  and the 
sec  mutants  which  have  End-  phenotypes  but  possess 
temperature-conditional mutations in essential genes (No- 
vick and Botstein,  1985; Riezman,  1985; Chvatchko et al., 
1986).  The  growth  of various  Vsl-  mutants  on  SD  and 
SD/5FOA at 24°C is shown in Fig. 4. Some of the mutants 
(e.g.,  10,  121) gave rise to a few colonies which grew well 
on SD/SFOA and these presumably arose by mutation at sup- 
prcssor loci or gene conversion of vat2A by the plasmid copy 
of the gene before plasmid loss. The number of these colo- 
nies varied from one experiment to another, but most of the 
cells that lost the plasmid gave microcolonies on SD/SFOA. 
Cells that are URA3 (e.g., cells which have not lost the plas- 
mid) do not even form microcolonies on SD/SFOA (data not 
shown).  The inability of the Vsl- mutants to grow on SD/ 
5FOA was not due to integration of pCY36 into the chromo- 
some or gene conversion of the chromosomal ura3 mutation, 
because  when  mated to  the  wild-type  ura3  MATc~ strain 
RH449,  all  the  resulting  diploids  were  able  to  grow  on 
SD/SFOA. 
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Figure 3.  The vat2-synthetic  lethality  (Vsl-)  mutant screen.  The 
starting strain was RH1937, which has a chromosomal deletion of 
the VAT2  gene (vat2A) marked  with LEU2 and a centromere plasmid 
(pCY36) carrying the wild-type VAT2  and URA3  genes. After muta- 
genesis,  some of the cells will gain a new mutation which prevents 
growth without a wild-type copy of VAT2 (Vsl-). SD/5FOA is used 
to select for those ceils in each colony of mutagenized RH1937 
which have lost the pCY36  plasmid during growth and become 
Ura-. None of the cells in the Vsl- mutant colonies will be able to 
grow on SD/5FOA, since they cannot grow without the VAT2  gene. 
On the other hand, cells  in the Vsl  + colonies can lose the pCY36 
plasmid.  Those  Vsl  +  cells  which  do  become  Ura-  will  grow 
on SD/5FOA. 
The results of complementation analysis performed after 
the first hackcross suggested that mutants 38 and 43 are in 
one complementation  group and  the  other  five End-  Vsl- 
mutants are in distinct complementation groups. The defini- 
tion of six  complementation  groups was confirmed in the 
complementation analysis based on temperature-sensitivity 
described later. 
Many of  the Vsl- Mutants Are Defective for Lucifer 
Yellow Accumulation in the Vacuole 
We examined  the ability  of the  Vsl- mutants  to carry out 
fluid-phase endocytosis by assaying the accumulation of the 
fluid-phase marker LY in the vacuole (Materials and Meth- 
ods).  One of the Vsl- mutants (113) had no visible vacuole 
when viewed by Nomarski optics and therefore could not be 
tested for LY accumulation (data not shown).  Each of the 
other mutants had either a  few small vacuoles or one large 
vacuole (Fig.  5, B-G) similar to the wild-type strain (Fig. 
Figure 4.  Growth of Vsl-  mutant  strains  on SD (I),  but not on 
SD/5FOA (II). The mutant strains  10 (RH1972) (A), 19 (RH1973) 
(B), 38 (RH1974) (C), 43 (RH1975) (D), 72 (E), 95 (F), 113 (G), 
121 (H), 62 (RH1976) (I), 73 (RH1977) (J), 82 (RH1978) (K), and 
the wild-type strain RH1937 (L) were streaked out on SD (pH 5.5) 
and on SD/SFOA (pH 5.5) plates and allowed to form colonies at 
24°C. Only the wild-type parent strain RH1937 (L) is able to form 
a large number of fast-growing colonies on SD/5FOA plates.  Some 
strains,  e.g.,  RH1972  (A) and  121  (H),  occasionally give slow- 
growing colonies on SD/5FOA plates,  but the majority of cells do 
not grow or form only microcolonies on this  medium. Ura  + cells 
do not even form microcolonies on SD/5FOA plates.  Mutants 10, 
19,  38,  43,  62,  73,  and  82  are  End- (endl3-1, end8-1, endl2d, 
endl2-2, end9-1, endlO-1, and endll-1, respectively,  see Table I), 
while 72, 95,  113, and  121 are not. 
5 A). Mutants  10,  19, 38, 43, 62, 73, and 82 (7 of 18 total) 
were defective for accumulation of LY in the vacuole at 24°C 
(Fig. 5, B'-G') compared to the wild-type strain (Fig. 5 A'), 
while most of  the other mutants showed approximately wild- 
type levels of LY accumulation in the vacuole at 24°C (data 
not shown). The mutant 82 showed a unique staining pattern 
with LY. In certain cells it was possible to see a faint reticular 
staining  surrounding  the  vacuole,  suggesting  that perhaps 
this mutant took up some LY but did not deliver it to the 
vacuole.  This staining was very faint and is not obvious in 
Fig.  5. 
Those  Vsl-  mutants  which  had  defects  in  endocytosis 
were designated end mutants.  Thus mutants  10,  19,  38/43, 
62, 73, and 82 define END13, END& END12, ENDg, ENDIO, 
and ENDll, respectively. 
Munn and Riezman Vacuolar Acidification  and Endocytosis Mutants  377 Table H A.  Synthetic  Lethality of vat2A::LEU2 and end3A::URA3 Mutations 
Tetrad class  PD  T  NPD  Total 
Phenotypes of spores  2  Leu  + Ura-  1 Leu  +Ura-  2  Leu- Ura- 
2  Leu- Urn  +  1 Leu- Ura+  2  Inviable 
1 Leu- Ura- 
1 Inviable 
Genotype of spores  2  vat2A END3  1 vat2A END3  2  VAT2 END3 
2  VAT2 end3A  1 VAT2 end3A  2  vat2A end3A 
I  VAT2 END3  (inviable) 
1 vat2A end3A 
(inviable) 
Number of tetrads  9  21  9  39 
The diploid strain RHI931  (vat2A::LEU2/VAT2 end3A::URA3/END3 ura3/ura3 leu2/leu2) was sporulated, and the tetrads obtained were dissected onto YPUAD 
(pH 5) medium. Colonies were allowed to form at 24"C. The nutritional requirements of the haploid segregants arising from the spores, and the deduced genotypos 
of the haploid segregants with respect to END3 and VAT2 were determined. Tetrad ratios for RH1931 (PD, T, NPD) are shown. PD, parental ditype; T, tetratyp¢; 
NPD, nonparental ditype. 
Table H B.  Synthetic  Lethality of vat2A::LEU2 and 
end4A':LEU2 Mutations 
Tetrad class  PD  T  NPD  Total 
Phenotypes of  4  Leu  +  2  Leu  ÷  2  Leu- 
spores  1 Leu-  2 Inviable 
1 Inviable 
Genotype  2 vat2A END4 1 vat2A END4 2 VAT2 END4 
of spores  2 VAT2 end4A 1 VAT2 end4A 2 vat2A end4A 
1 VAT2 END4  (inviable) 
1 vat2A end4A 
(inviable) 
Number of  5  22  9  38 
tetrads 
The  diploid  strain  RH2464  (vat2A::LEU2/VAT2 end4A::LEU2/END4  leu2/ 
leu2) was sporulated,  and the tetrads  obtained were dissected onto YPUAD 
(pH 5) medium. Colonies were allowed to form at 24"C.  The nutritional re- 
quirements of the haploid segregants arising from the spores, and the deduced 
genotypos of the haploid segregants with respect to END4 and VAT2 were de- 
termined.  Tetrad ratios for RH2464 (PD, 7", NPD) are shown. Incuded in the 
total are  two tetrads  which did not  fall into PD,  T, or NPD classes due to 
insufficient viable  spores recovered  or to gene conversion  events leading to 
aberrant  marker  segregation  ratios.  PD, parental  ditype;  T,  tetratype; NPD, 
nonparental ditype. 
end8-1, end9-1, endlO-l, and endll-I Mutants Exhibit 
Defects in Uptake of t~-Factor Pheromone 
Using LY as a marker, it is possible to determine if cells have 
a defect in endocytosis, but is not possible to show whether 
the defect lies in uptake at the plasma membrane or in subse- 
quent delivery to the vacuole. To determine where the endo- 
cytic defect lies, we assayed each of the new end mutants for 
internalization  of a-factor at 24 and  37°C  (Materials  and 
Methods). Uptake of a-factor exhibited nearly wild-type ki- 
netics at 37°C in the endl2d, endl2-2, and endl3d mutants 
(Fig. 6, E and F, data for endl2-2 not shown), but was clearly 
defective in the end8-1, end9-1, endlO-1, and endll-1 mutants 
(Fig.  6,  A-D).  Interestingly,  uptake  of a-factor exhibited 
wild-type kinetics at 24°C in the end8-1 mutant (Fig. 6 A), 
and  was  significantly  faster at 24°C  than  at  37°C  in the 
end9-1 mutant. ~Factor uptake by the endll-1 mutant (Fig. 
6 D) was defective at both temperatures, although the initial 
rate of uptake (first 5 min) was nearly like that in the wild- 
type strain. After 15 rain at 37°C, the endll-1 mutant stopped 
accumulating internalized a-factor as there was no further 
increase in internal counts. At this time point only '~50-60% 
of the bound pheromone was resistant to an acid wash. The 
defect in a-factor uptake shown by the endlO-1 mutant (Fig. 
6 C) was similar to that exhibited by the endll-1 mutant, ex- 
cept that in the former mutant the noninternalized a-factor 
dissociated rapidly from the cells. 
The end124, end12-2,  and endl3-1 
Mutants Are Defective in Degradation of 
Internalized u-Factor 
To measure later steps of endocytosis, we tested those end 
mutants which were defective for LY accumulation but were 
not defective for a-factor uptake, for a-factor degradation at 
30°C  (Materials  and  Methods).  We  chose  30°C  because 
pheromone delivery to the vacuole is optimal at this temper- 
ature. The results of these experiments are shown in Fig. 7. 
The end13-1 mutant showed a strong delay in degradation of 
internalized  a-factor at  30°C  compared to  the  wild-type 
strain and the endl2-1 (and endl2-2) mutants show almost no 
degradation  of the  internalized  a-factor even at late time 
points  (90).  The  end//-/  mutant  also  showed  very  little 
degradation  of the  small  amount  of internalized  a-factor 
(data not shown). 
The endl2-1 and encU3-1 Mutants Missort Newly 
Synthesized Vacuolar Hydrolases 
In  yeast,  soluble  vacuolar proteins  transit  through  endo- 
somal compartments on their way to the lysosome or vacuole 
(Schimm611er and Riezman,  1993;  Raymond et al.,  1992; 
Vida et al., 1993; Davis et al., 1993). It is therefore possible 
that certain mutations that block or delay transport between 
endosomal compartments or from endosomal compartments 
to the vacuole might cause a defect in the correct sorting and 
maturation  of  soluble  vacuolar  hydrolases.  We  therefore 
screened the new end mutants for secretion of carboxypepti- 
dase Y (CPY), a soluble glycoprotein of the yeast vacuole. 
The end mutants were grown on a  nitrocellulose  filter at 
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Phenotyp¢  Ura- Leu-  Ura- Leu  +  Ura  + Leu-  Ura  + Leu  + 
Genotype  END3 VAT2  END3 vat2A  end3A VAT2  end3Avat2A  Total 
Number observed  36  40  41  0  117 
Number Case  1  39  39  39  0  117 
Number Case 2  39  39  39  39  156 
The total number of spores of each genotype obtained by dissection of 39 tetrads of RH1931 are shown. The data is from the experiment described in Table II 
A. The number expected if end3A and vat2A are unlinked and show synthetic lethality (Case 1), and if end3A and vat2A are unlinked and do not show synthetic 
lethality (Case 2) are also shown. 
24°C and CPY secreted by the cells was detected using a 
specific polyclonal antiserum (Materials and Methods). The 
result is shown in Fig. 8. The endl2-1  and end13-1 mutants 
were positive for the presence of CPY on the filter and the 
endS-l, end9-1, and endll-1 mutants were negative as was the 
wild-type strain. The results obtained with the endlO-1 mu- 
tant were intermediate and probably reflect some cell lysis 
(see below). 
To further analyze delivery of CPY to the vacuole, we per- 
formed a  pulse-chase  radiolabeling  of newly  synthesized 
CPY in each end mutant. CPY is synthesized as a precursor 
(prepro-CPY) with an NH2-terminal signal sequence and is 
translocated into the lumen of the ER.  In the ER,  CPY 
receives four core oligosaccharides to yield a protein of 67 
kD known as pl CPY. CPY is then transported to the Golgi 
where it receives outer chain mannose residues and increases 
in size to 69 kD (p2 form). From the Golgi, the CPY is trans- 
ported to the vacuole where it is cleaved to a 61-kD form 
which is the mature, active species. The formation of 61 kD 
CPY is indicative of correct vacuolar delivery of CPY (for 
review see Rothman et al.,  1989; Klionsky et al.,  1990). 
The new end mutants were pulse-labeled with Na235SO, 
or [35S]methionine  and cysteine, chased with cold sulfate, 
methionine, and cysteine, and separated into intraceUular 
and extraceUular (including perplasmic) fractions. Labeled 
newly synthesized CPY was immuneprecipitated at various 
time points after initiation of the chase from both fractions 
and  displayed  on  SDS-PAGE  gels  (Fig.  9).  The  endS-l, 
end9-1,  endlO-1,  end11-1, and  endl3-1  mutants  exhibited 
wild-type kinetics of CPY  maturation in the intracellular 
fractions whereas the end12-1 mutant was severely defective 
for maturation of CPY.  Although the end13-1 mutant ma- 
tured  intracellular  CPY  with  wild-type kinetics,  a  small 
amount of the newly synthesized CPY was secreted as p2 
CPY into the extracellular fraction. Thus, the pulse-chase 
labeling data agrees with the filter immunoassay data, and 
shows  that only end124  (and  end12-2)  and  end13-1 have 
defects in delivery of CPY to the vacuole. Since these mu- 
tants were also defective in degradation of internalized a-fac- 
tor, this result is consistent with the idea that delivery of 
newly synthesized CPY to the vacuole and late steps in en- 
docytosis require common gene products. Further work will 
be needed to establish that the a-factor degradation pheno- 
types of these mutants are really due to transport blocks and 
are not due to a lowered ability of the vacuoles in these mu- 
tants to degrade c~-factor. 
All of the New end Mutants Affect Nuclear Genes and 
Display Defective Growth at Elevated Temperatures 
All of the new end mutants (with the exception of endl2-2, 
which is allelic to endl2-1) were outcrossed to the congenic 
wild-type  strains  RH449  (once)  and  RH977  or  RH978 
(twice). The defect in uptake of LY segregated 2:2 in every 
tetrad  examined,  indicating  that  the  End-  phenotype  is 
caused by a lesion in a nuclear-encoded gene. In addition, 
an  unselected  defect  in  growth  at  elevated  temperature 
segregated with each endocytic defect. The end8-1, end9-1, 
endlO-1, and end12-1 (and end12-2) mutants caused a tight 
block in growth at 37°C,  whereas the end11-1 strain grew 
poorly at all  temperatures tested  (24  and  37°C)  and  the 
end13-1 strain was only completely defective for growth at 
39°C (the wild-type strain grew slowly at this temperature). 
The Ts- in each end mutant was complemented in heterozy- 
gous diploids. Hence the Ts- phenotype which cosegregates 
with each end mutation is recessive. 
Other mutants have been isolated in our laboratory and in 
other laboratories that affect the internalization step of en- 
docytosis. Among these are chcl-521 (clathrin heavy chain) 
(Payne et al.,  1988; Tan et al.,  1993), clclA (clathrin light 
chain) (Silveira et al., 1990), act1-1 (actin) (Novick and Bot- 
stein,  1985; Kiibler and Riezman,  1993), sac6A (fimbrin) 
(Adams et al.,  1991;  Kiibler and Riezman,  1993), cmdl-1 
(calmodulin) (Davis, 1992; Kiibler, E., E  Schimmtller, and 
H. Riezman, manuscript in preparation), end3-1 (Raths et 
al.,  1993), end4-1 (Raths et al.,  1993), endS-l, end6-1, and 
endT-1 (Munn, A. L., and H. Riezman, unpublished data). 
All of these mutants, like the new end mutants, exhibit tem- 
perature-sensitive growth.  We tested each of the new end 
mutants for complementation with these mutants. All pair- 
wise combinations exhibited complementation. All the mu- 
tations were recessive to the wild-type allele in heterozygous 
diploids (data not shown). Hence, the new end mutants iso- 
lated in the Vsl- screen that are defective in the internaliza- 
tion step identify a new set of genes required for fluid-phase 
and receptor-mediated endocytosis in yeast. 
The end12 and end13 mutants, which show a vacuolar pro- 
tein sorting (vps) phenotype, were tested by complementa- 
tion analysis with the vps mutant collection (Raymond et al., 
1992). end12 did not complement vps34, and end13 did not 
complement vps4. Therefore, the new screening procedure 
also identifies a subset of vps mutants that affect the endo- 
cytic pathway (see Discussion). 
Discussion 
In previous work, two yeast mutants blocked in the first step 
of endocytosis were isolated. These mutants carried lesions 
in distinct genes, END3 and END4 (Raths et al.,  1993). In 
this study, we have shown that the combination of end3A or 
end4A mutations with a vat2A mutation resulted in spores 
Munn and Riezman  Vacuolar Acidification  and Endocytosis  Mutants  379 Figure 5. Some Vsl- mutants are defective for accumulation of LY in the vacuole (End-). The wild-type strain RH144-3D (END) (A) and 
the three time outcrossed mutants  10 (endl3-1)  (RI-I2604)  (B),  19 (endS-l) (RH2607) (C),  38 (endl2-1)  (RH2611) (D),  62 (endg-1) 
(RH2615)  (E), 73 (endlO-1) (RH2618)  (F), and 82 (endll-1)  (RH2622) (G) were assayed for accumulation of LY in the vacuole at 24"C 
as described in Materials  and Methods. The upper panel in each pair (A-G) shows a field of cells viewed with Nomarski optics,  and the 
lower panel in each pair (A'-¢7) shows the same field of cells viewed with FITC-fluorescenee  optics.  The vacuoles in each cell are visible 
as indentations  when observed with Nomarski filters.  If the vacuoles have accumulated LY, then they are also visible with fluorescence 
optics.  All the mutants shown have vacuoles which are clearly visible  in the Nomarski photographs, but which are unstained or stained 
poorly with LY compared to the wild-type strain  in the fluorescence photographs.  The original mutants RH1972  (endl3-1),  RH1973 
(endS-1), RH1974 (endl2-1),  RH1975 (endl2-2), RH1976 (end9-1), RH1977 (endlO-1), and RH1978 (endll-1) have similar defects in LY 
accumulation. 
that germinated but did not give rise to colonies. Therefore, 
it seems that in the absence of the normal mechanism for 
acidification of the vacuolar system,  endocytosis of acidic, 
external fluid can allow vat2A mutant cells to grow. When 
these ceils are also unable to endocytose, the vacuolar sys- 
tem cannot be acidified and this leads to lack of growth con- 
sistent with the hypothesis put forward by Nelson and Nelson 
(1990).  It is quite possible that the rate at which the vat2A 
cells acidify their vacuolar system by endocytosis is limiting 
for growth and is responsible for their slow generation time. 
The Journal of Cell Biology, Volume 127, 1994  380 Figure  5. 
The experiments described in this report suggest the possi- 
bility that an organelle(s) of the vacuolar or secretory system 
must be  acidified to allow  growth.  Further work will be 
needed to determine whether or not this is true. Ifa compart- 
ment is being acidified via endocytosis, however, several ob- 
servations may be useful clues to the identity of  this compart- 
ment. First, not all mutations that affect accumulation of LY 
in the vacuole are synthetically lethal with vat2 mutations. 
In  particular,  the ypt7 mutation,  which  delays  endocytic 
traffic from late endosomes to vacuoles, is not synthetically 
lethal with vat2 (Schimm611er  and Riezman,  1993; Schim- 
m611er, E, unpublished observations). On the other hand, 
some mutants  that affect postinternalization stages  of en- 
docytosis, e.g., the endl2-1,  endl2-2, and endl3-1  mutants 
described here, are synthetically lethal with vat2. This sug- 
gests that if uptake of the acidic medium is important for 
growth,  uptake alone is  not sufficient and  its delivery to 
some internal compartment(s) of the endoeytic or perhaps 
secretory  pathway is also required. In any event, it is unlikely 
that the vacuole must be acidified, because it is known that 
some yeast mutants remain viable without functional vacu- 
oles (Dulfc and Riezman,  1990). Further experiments will 
be  required to  determine if there is  an  organelle whose 
acidification is essential and, if so, the identity of this or- 
ganelle. 
By screening for mutations that are colethal with vat2A 
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The  Journal  of  Cell  Biology,  Volumo  127,  1994  382 Figure 7. The End- mutants which are wild-type for u-fatcor uptake (lO/end134 and 38/end12-1) are defective for u-factor degradation. 
The three time outcrossed mutants  10 (endl3-1)  (RH2604)  (13) and 38 (endl2-1)  (RH2611) (12) and the wild-type strain (RH144-3D) 
(WT) were assayed for u-factor degradation  using a pulse-chase protocol  as described  in Materials  and Methods.  Mutant  10 (end13-1) 
degrades the u-factor with slow kinetics, while mutant 38 (endl2-1) is nearly completely blocked in u-factor degradation.  Quantification 
of the intact a-factor remaining at different time points by laser densitometry  (using the fluorograms shown) indicates that in RH144-3D 
only 34% of the internalized  u-factor is intact at 30 min, while in RH2604 and RH2611, 70% and 93% of the internalized u-factor is 
intact at 30 rain,  respectively. By 90 rain, only 7% of the internalized u-factor is intact in RH144-3D, while at the same time 16% and 
64% of the internalized  u-factor is intact  in RH2604 and RH2611, respectively. 
(Vsl-),  we isolated seven new mutants that have endocytic 
defects. These mutants define six complementation groups 
(ENDS-END13). Therefore, it seems likely that more genes 
required for endocytosis will be identified by further screens 
for Vsl- mutants.  Of the new mutants, four affect uptake of 
endocytic markers into the cell (end8-1,  end9-1,  endlO-1, and 
endll-1) and three may affect subsequent delivery of internal- 
ized material to the vacuole (end12-1, end12-2, and endl3-1). 
The uptake-defective mutants are able to deliver and mature 
the  soluble vacuolar protein  CPY  with wild-type kinetics 
and do not secrete this protein to the cell surface. In this re- 
spect, they resemble end3 and end4 mutants. In contrast, the 
three mutants which may affect subsequent steps in the endo- 
cytic pathway (end12-1,  endl2-2,  and end13-1) are defective 
for delivery of newly synthesized CPY to the vacuole.  At 
least a portion of the newly synthesized CPY in these latter 
mutants reaches the extracellular medium in the p2 form. 
The secretion of vacuolar hydrolases by endl2 and end13 
mutant yeast cells makes the interpretation of the a-factor 
degradation experiments more difficult. Perhaps these mu- 
tants are defective in degradation of the internalized a-factor 
because of a deficiency in vacuolar protease activity and not 
because of a delay in delivery of u-factor to the vacuole. We 
believe that there is a delay in a-factor transport to the vacu- 
ole because the accumulation of LY in the vacuole is also 
blocked in these mutants. Accumulation of LY in the vacuole 
does not require vacuolar proteases and several vps mutants 
which we have tested, including vpsl  and vps3 which have 
strong CPY missorting phenotypes (Raymond et al.,  1992), 
accumulate LY in the vacuole as well as wild-type cells (data 
not shown). The slow degradation of or-factor in the end13-1 
mutant may be consistent with a strong delay in transport of 
u-factor to the vacuole. This slow degradation is reminiscent 
of that seen in ypt7mutant yeast and may reflect degradation 
in  a  prevacuolar/endosomal compartment in  which  newly 
synthesized vacuolar hydrolases accumulate (Schimmfller 
and Riezman, 1993). In future experiments we will use cell 
fractionation techniques to follow the intracellular distribu- 
tion of c~-factor at various times after internalization. These 
experiments will allow us to determine whether there is a 
transport block in the endocytic pathway in the end12/vps34 
and endl3/vps4  mutants and which  steps in the  endocytic 
pathway are affected. If  there is a defect in transport of u-fac- 
tor to the vacuole in these mutants,  we should be able to 
identify the compartment in which the or-factor accumulates. 
The isolation of alleles of vps4 and vps34 in our mutant 
Figure 6. Some of the End- mutants are defective in or-factor internalization.  Continuous presence c~-factor  uptake assays were performed 
at 24°C and at 37°C as described  in Materials  and Methods on the wild-type strain RHI44-3D (END) (shown in each graph A-F) and 
the three  time outcrossed  mutants  19 (endS-l) (RH2607)  (A),  62 (end9-1)  (RH2615) (B),  73  (endlO-1) (RH2618) (C),  82 (endll-1) 
(RH2622) (D), 38 (endl2-1) (RH2611) (E), and 10 (end13-1) (RH2604) (F). Mutants 19 (endS-l) and 62 (end9-1) (A and B) are defective 
in internalization even at early time points at 37°C, but uptake is less defective (or not defective) at 24°C. Mutants 73 (endlO-1) and 82 
(endll-1)  (C and D) internalize a-factor like wild-type initially, but then uptake slows down when ,~40-50% of the ,~-factor is internal, 
i.e., after 10-15 min. Mutants  10 (endl3-1) and 38 (endl2-1) (E and F) internalize u-factor like wild-type at 24°C and 37°C. Data shown 
is the average of at least four independent assays. 
Munn and Riezman Vacuolar  Acidification and Endocytosis Mutants  383 Figure 8.  The  End-  mutants  which  are  defective  for  u-factor 
degradation secrete soluble  vacuolar proteases.  Three time out- 
crossed mutants 10 (endl3-1) (RH2604),  19 (endS-l)  (RH2607), 
38  (endl2-1) (RH2611),  62  (end9-1) (RH2615),  73  (endlO-1) 
(RH2618),  and 82  (endll-1) (RH2622) as well  as the wild-type 
strain RH144-3D (END) and the vpsl strain as a positive  control 
were grown on a nitrocellulose  filter  at 240C,  After two days of 
growth, the cells  were washed  from the filter  and the filter  was 
probed with antiserum raised against carboxypeptidase Y (CPY) to 
visualize  CPY  which  had  been  secreted  during  growth  (see 
Materials  and  Methods).  The endl2-1 and endl3-1 mutants  are 
strongly positive, as is the vpsl strain. The endlO-1 mutant is faintly 
positive.  The endS-l, endg-l, and endll-I mutants are negative like 
the wild-type strain RH144-3D. 
screen is significant. The vps4 mutants are of  the class E type 
as described by Raymond et al.  (1992).  They have vacuoles 
of wild-type morphology, however soluble vacuolar proteins 
such as CPY accumulate in a compartment adjacent to, but 
distinct  from,  the vacuole.  This  "class E  compartment" is 
acidified and the vacuolar H+-ATPase is associated with it. 
Raymond et al.  (1992) have suggested that it may be an en- 
dosomal/prevacuolar intermediate  lying between the Golgi 
complex and the vacuole. It is notable also that the renl mu- 
tant isolated by Davis et al.  (1993),  which exhibits a  delay 
in uptake and/or transport of the a-factor receptor (Ste3p) 
is allelic to vps2, another class E  vps mutant. 
In contrast to vps4, vps34 mutants are of the class D type. 
Class D vps mutants have vacuoles that are often larger than 
those seen in wild-type cells (Raymond et al., 1992). Never- 
theless,  class D  mutants have stronger defects in growth at 
elevated temperature,  growth in high osmolarity medium, 
and in vacuolar protein sorting compared to class E vps mu- 
tants.  The vacuole is not strongly acidified in these mutants 
and the vacuoles are  not able to  segregate efficiently into 
daughter cells during mitosis (Banta et al.,  1988; Raymond 
et al.,  1992). 
A better understanding of  the role of  the FPS34 gene prod- 
uct in vacuolar protein sorting has been gained by the discov- 
ery that it possesses  a  phosphatidylinositol  3-kinase  (PI3- 
kinase) activity and has amino acid homology to the catalytic 
subunit (pll0) of mammalian PI3-kinase (Hiles et al., 1992; 
Herman et al.,  1992). In mammalian cells, PI3-kinase is as- 
Figure 9.  All the new End- mutants except  38 (endl2)  process 
soluble  vacuolar  protease  precursors  like  the  wild-type  strain 
RH144-3A.  Three  time  outcrossed mutants  endS-1 (mutant  19) 
(RI-I2608) (8), end9-1 (mutant 62) (RH2616) (9), endlO-1 (mutant 
73) (RH2619)  (10), endll-1 (mutant 82) (RH2623)  (11), end124 
(mutant 38) (RI-I2612) (12), end134 (mutant 10) (RH2605) (13) as 
well as the END strain (RHI44-3A) (WT) were metabolically la- 
beled  with  Na235SO4 or  with  [3SS]methionine and  -cysteine  at 
37°C, and then chased with cold Na235SO4, methionine,  and cys- 
teine at the same temperature.  After various times of chase (0, 5, 
10, and 30 min), samples of cells were removed and protein trans- 
port was terminated  with azide and fluoride.  The samples  were 
separated into cellular and extracellular  fractions and CPY was im- 
muneprecipitated  from each fraction.  The immunecomplexes  were 
resolved on SDS-PAGE gels and the immuneprecipitated  CPY was 
visualized  by fluorography.  The cellular fractions from each time 
point are shown on the left,  and the extracellular  fractions from 
each time point are shown on the fight, p/is the core-glycosylated 
(endoplasmic  reticulum)  form of CPY, p2 is the (outer chain man- 
nose) Golgi form of CPY, and m is the mature (vacuolar)  form of 
CPY. The large numbers designate  the end gene affected,  e.g., 8 
is endS-1 and 9 is endg-1, and WT is RH144-3A.  The endl2-1 mu- 
tant (12) fails to process CPY to the mature form efficiently and se- 
cretes the p2 form. All other mutants process CPY with wild-type 
kinetics.  Notice that the endl3 mutant (13) secretes  some p2 CPY 
as well,  in agreement with the results  shown in Fig.  8. The small 
amount ofpl and p2 CPY present in the extracellular  fractions from 
the wild-type strain and the endg-1 and endll-1 strains  is probably 
released  by occasional lysis  of the labeled  cells  during  sphero- 
plasting. 
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kinase activity and it has been suggested that PI3-kinase may 
be required both for signal transduction from these receptors 
and perhaps  for their internalization (Panayotou and Wa- 
terfield, 1992). In this respect it is interesting that we see no 
defect in internalization of  a-factor in the endl2-1 and endl2-2 
mutants. The defect in endocytosis lies at a later step in the 
pathway. 
There are four possible explanations for the defects in the 
vps34 mutant. (/) It is possible that Vps34p  is required for 
budding or transport of vesicles from an endosome/prevacu- 
olar compartment to the vacuole. This step is probably re- 
quired for both vacuolar hydrolase delivery and for delivery 
of  endocytosed material to the vacuole. (2) Vps34p may prin- 
cipally be involved in targeting of proteins from the Golgi 
apparatus to endosomes. In this case, a protein that is essen- 
tial for transport of endocytic material from endosomes to- 
wards the vacuole would not be delivered to its site of action, 
and  an  indirect  block  of  endocytosis  would  ensue.  (3) 
Vps34p could be directly required for the recycling of essen- 
tial Golgi components from endosomes back to the Golgi. 
This could cause a depletion of the vacuolar protein sorting 
machinery in the Golgi, and an accumulation of this ma- 
chinery in endosomes, thus possibly impairing endosomal 
function. (4) Vps34p could be working independently in the 
two pathways, controlling the sorting of vacuolar hydrolases 
in the Golgi, and the sorting of proteins in endosomes for 
traffic to different destinations including the plasma mem- 
brane, Golgi, and the vacuole. Experiments using a vps34 
mutant that is temperature-sensitive for function may be 
valuable in distinguishing between these possibilities. 
The end12/vps34 mutations have much stronger effects on 
maturation of  vacuolar hydrolases than the endl3-1 mutation, 
and it may be that the effect  ofendl3-1 on delivery of  vacuolar 
hydrolases is not direct. For example, the endJ3-1 mutation 
may not affect the compartments through which vacuolar 
hydrolases pass, but a communicating compartment. A de- 
fect in the latter compartment may then have a delayed effect 
on the function of the former compartments and lead to mis- 
sorting of vacuolar hydrolases. 
The uptake-defective end mutants can be divided into two 
classes. One class contains end8-1, endg-1, end& and end4. 
This class is affected in initial and subsequent uptake ki- 
netics. A  second class of mutant contains the endlO-1 and 
endll-1  mutants. These are affected in uptake of receptor- 
ligand complexes also, but the defect does not occur immedi- 
ately after addition of ligand. These mutants show nearly 
normal initial or-factor  uptake kinetics, but uptake appar- 
ently reaches a plateau after 5-10 min of internalization. The 
first class of mutant is probably directly affected in uptake 
of ~t-factor.  Several  explanations  could  account  for  the 
phenotype of the second class of mutant. (a) A component 
necessary  for uptake  of a-factor could become depleted 
shortly after internalization commences. This explanation is 
unlikely, since fluid-phase endocytosis is also affected in 
these mutants and it occurs constitutively. (b) A block in en- 
docytic transport to the vacuole from certain intermediate 
organelles  (e.g.,  transfer  from early  to  late  endosomes) 
might lead to recycling of receptor-ligand complexes from 
these intermediates back to the surface, thus producing a 
new equilibrium with approximately equal uptake and recy- 
cling rates. In support of this proposal, the small amount of 
internalized o~-factor appears not to be degraded with wild- 
type kinetics in the endll-1 mutant (data not shown). Further 
experiments are currently underway to directly address this 
question. 
Interestingly, all but one of the mutations isolated on the 
basis of their Vsl- phenotype segregated in crosses with a 
tightly linked temperature-sensitive growth phenotype. This 
Ts-  phenotype was  most pronounced  in  end8-1,  end9-1, 
endlO-1, endl2-1, and endl2-2, and the cells were unable to 
grow at all at 37°C. The growth of endl3-1 cells was partially 
impaired at 37°C, and was completely blocked at 39°C. This 
result extends our previous observation that end3 and end4 
mutants were Ts- for growth and supports our speculation 
that at least one step of the endocytic pathway is essential for 
growth at elevated temperature. Of the new mutants, only 
endl]-I was not strongly defective in growth at high tempera- 
ture. It remains to be determined whether the defect in end//-/ 
is partial, or whether ENDll is not essential for growth at 
elevated  temperatures.  The  ypt7  mutant  is  not  Ts-  for 
growth, even though it has a  strong defect in endocytosis 
(Wichmann et al., 1992; Schimm611er and Riezman, 1993). 
This protein seems to act at one of the latest stages of the 
endocytic pathway: transport out of the late endosome. It 
could be that late steps are not required for growth at elevated 
temperature or that the function required for growth at high 
temperature is provided by another protein in ypt7 mutant 
strains. 
The Ts- growth defect exhibited by the new end mutants 
will allow rapid cloning of the wild-type genes by com- 
plementation. Further characterization of the mutants de- 
scribed here and a molecular analysis of the corresponding 
genes will lead to a greater understanding of the cellular ac- 
tivities and structures required for endocytosis in yeast. 
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